Jim Cramer's Mad Dash: HTZ REGN
Cramer said the unit is worth about $4.5 billion. Shareholders should be pleased. The company has an enterprise value of $28 billion -- with quite a bit of debt -- and a market cap of only $12 billion.
A lot of hedge funds are also involved in the stock, he said, and it will be interesting to see if they take profits on Monday's news or stay invested in the company.
Turning to Regeneron Pharmaceuticals
Cramer called Regeneron's Leonard Schleifer "one of my favorite CEOs."
However, Cramer warned Regeneron and Biogen